A Clinical trial to study the effectiveness of Laghumanjishthadi kwath in the management of Vatarakta(Gout)

A Clinical study on the efficacy of polyherbal compound in the management of Vatarakta(Gout)

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/053846

Enrollment

Registered

2023-06-14

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients presented with classical symptoms of Vatarakta as mentioned in classical texts (joint pain, swelling, stiffness, reddish blackish discoloration of skin and burning sensation) 2.Raised serum uric acid levels more than 7 mg/dl 3.People of both sexes all socioeconomic conditions and ethnicity 4.Patients willing to participate in the study

Exclusion criteria

Exclusion criteria: 1.Age less than 30 years and more than 70 years 2.Presence of complications of systemic illnesses like nephropathy chronic liver disease 3.Presence of diseases like Carcinoma HIV malignant hypertension uncontrolled diabetes 4.Presence of other joint illnesses like osteoarthritis rheumatoid arthritis SLE 5.Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
To decrease the symptoms of the affected joint as mentioned below 1. Joint pain 2. Stiffness 3. Swelling 4. Reddish blackish discoloration of skin 5. Burning sensationTimepoint: 90 days	—

Secondary

Measure	Time frame
To achieve normal serum uric acid & CRP levelsTimepoint: 90 days	—

Countries

India

Contacts

Public ContactDr Ranjan Kalita

Government Ayurvedic College and Hospital Guwahati

gunjana12345@gmail.com7217869308

Outcome results